BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17654345)

  • 1. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages.
    Chan ED; Kaminska AM; Gill W; Chmura K; Feldman NE; Bai X; Floyd CM; Fulton KE; Huitt GA; Strand MJ; Iseman MD; Shapiro L
    Scand J Infect Dis; 2007; 39(8):690-6. PubMed ID: 17654345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes and serum level of alpha-1-antitrypsin in lung cancer.
    Topic A; Ljujic M; Petrovic-Stanojevic N; Dopudja-Pantic V; Radojkovic D
    J BUON; 2011; 16(4):672-6. PubMed ID: 22331720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease.
    Chan ED; Bai X; Kartalija M; Orme IM; Ordway DJ
    Am J Respir Cell Mol Biol; 2010 Oct; 43(4):387-93. PubMed ID: 20081053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
    DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
    Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
    Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?
    Schmechel DE
    Neurotoxicology; 2007 Sep; 28(5):899-914. PubMed ID: 17659342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
    Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
    Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
    van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
    Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
    Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
    Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of alpha-1 antitrypsin deficiency.
    Ranes J; Stoller JK
    Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.
    Corda L; Medicina D; La Piana GE; Bertella E; Moretti G; Bianchi L; Pinelli V; Savoldi G; Baiardi P; Facchetti F; Gatta N; Annesi-Maesano I; Balbi B
    Respiration; 2011; 82(5):418-25. PubMed ID: 21474916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues in genetic screening for susceptibility to chronic lung disease.
    Lappé M
    J Occup Med; 1988 Jun; 30(6):493-501. PubMed ID: 3292728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.
    Greene CM; Hassan T; Molloy K; McElvaney NG
    Expert Rev Respir Med; 2011 Jun; 5(3):395-411. PubMed ID: 21702661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders.
    Schmechel DE; Browndyke J; Ghio A
    Neurotoxicology; 2006 Sep; 27(5):637-57. PubMed ID: 16870258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic risk factor AAT deficiency. Also heterozygotes carry the risk of pulmonary emphysema].
    MMW Fortschr Med; 2006 May; 148(21):57. PubMed ID: 16796193
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-1-antitrypsin associated panniculitis: the MS variant.
    Geraminejad P; DeBloom JR; Walling HW; Sontheimer RD; VanBeek M
    J Am Acad Dermatol; 2004 Oct; 51(4):645-55. PubMed ID: 15389208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
    Shapiro L; Pott GB; Ralston AH
    FASEB J; 2001 Jan; 15(1):115-122. PubMed ID: 11149899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
    Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
    Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging identification of a novel PiISF and the rare PiMmaltonZ α1-antitrypsin deficiency variants in two patients.
    Suh-Lailam BB; Procter M; Krautscheid P; Haas J; Kumar S; Mao R; Grenache DG
    Am J Clin Pathol; 2014 May; 141(5):742-6. PubMed ID: 24713750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.